For the quarter ending 2025-09-30, LINE had -$7M decrease in cash & cash equivalents over the period. $35M in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | -112 | -7 |
| Provision for credit losses | 3 | 2 |
| Impairment of long-lived assets, goodwill, and other intangible assets | 30 | 1 |
| Gain on insurance recovery | 11 | 40 |
| Depreciation and amortization | 230 | 436 |
| (gain) loss on extinguishment of debt, net | -3 | 0 |
| Amortization of deferred financing costs, discount, and above/below market debt | 3 | 5 |
| Stock-based compensation | 38 | 69 |
| (gain) loss on foreign currency transactions, net | -6 | 42 |
| Deferred income tax | -4 | -9 |
| Put options fair value adjustment | -2 | -28 |
| (gain) loss on divestitures, net | -58 | - |
| Vesting of class d interests | 0 | - |
| One-time internalization expense to bay grove (see note 2, capital structure and noncontrolling interests) | 0 | - |
| Other operating activities | -5 | -1 |
| Accounts receivable | 0 | 36 |
| Prepaid expenses, other assets, and other long-term liabilities | 4 | 24 |
| Inventories | -5 | -15 |
| Accounts payable and accrued liabilities and deferred revenue | -18 | -6 |
| Right-of-use assets and lease obligations | -4 | 4 |
| Net cash provided by operating activities | 230 | 397 |
| Acquisitions, net of cash acquired | 2 | 439 |
| Purchase of property, plant, and equipment | 195 | 314 |
| Proceeds from sale of assets | 4 | 6 |
| Proceeds from insurance recovery on impaired long-lived assets | 11 | 38 |
| Investments in emergent cold latam holdings, llc | 2 | 7 |
| Proceeds from repayment of notes by related parties | 0 | 0 |
| Other investing activity | -3 | 2 |
| Net cash used in investing activities | -181 | -718 |
| Dividends and other distributions | 134 | 268 |
| Redemption of redeemable noncontrolling interests | 0 | 28 |
| Repurchase of common shares for employee income taxes on stock-based compensation | 2 | 10 |
| Redemption of common stock pursuant to put option exercise | 28 | - |
| Financing fees | 0 | 5 |
| Proceeds from long-term debt, net of discount | 0 | 495 |
| Repayments of long-term debt and finance leases | 34 | 156 |
| Payment of deferred and contingent consideration liabilities | 3 | 3 |
| Borrowings on revolving line of credit | 816 | 1,442 |
| Repayments on revolving line of credit | 616 | 1,238 |
| Settlement of put option liability | 50 | - |
| Issuance of common stock in ipo, net of equity raise costs | 0 | - |
| Redemption of units issued as stock compensation | 0 | - |
| Redemption of common stock | 0 | 0 |
| Redemption of opeus | 0 | - |
| Other financing activity | -3 | -3 |
| Net cash provided by financing activities | -54 | 226 |
| Impact of foreign exchange rates on cash, cash equivalents, and restricted cash | -2 | 2 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -7 | -93 |
| Cash and cash equivalents at beginning of period | 175 | - |
| Cash and cash equivalents at end of period | 75 | - |
Lineage, Inc. (LINE)
Lineage, Inc. (LINE)